https://www.parkerici.org https://www.parkerici.org/our-model https://www.parkerici.org/news https://www.parkerici.org/our-model/published-research https://www.parkerici.org/our-model/research-focuses https://www.parkerici.org/our-network/directory https://www.parkerici.org/our-model/discoveries 2026-10-01T13:51:41.022Z https://www.parkerici.org/about-us 2026-09-29T15:42:43.801Z https://www.parkerici.org/for-patients 2026-09-26T12:30:25.202Z https://www.parkerici.org/about-immunotherapy 2026-09-29T17:59:44.459Z https://www.parkerici.org/our-model/innovations 2026-09-29T19:42:36.742Z https://www.parkerici.org/transparency-in-coverage 2026-09-11T14:46:59.427Z https://www.parkerici.org/cookies 2026-09-17T09:23:01.005Z https://www.parkerici.org/terms-and-conditions 2026-09-11T14:46:59.664Z https://www.parkerici.org/privacy 2026-09-17T09:22:24.281Z https://www.parkerici.org/careers 2026-09-25T13:53:06.413Z https://www.parkerici.org/donate 2026-09-25T17:36:08.373Z https://www.parkerici.org/our-network/partners 2026-09-26T12:55:29.030Z https://www.parkerici.org/our-model/bioventures 2026-09-25T13:49:13.784Z https://www.parkerici.org/contact 2026-09-23T14:10:33.552Z https://www.parkerici.org/news/bristol-myers-squibb 2026-09-11T14:47:05.366Z https://www.parkerici.org/news/seres-therapeutics 2026-09-11T14:47:05.307Z https://www.parkerici.org/news/using-yourself-to-fight-cancer-with-jeff-bluestone-president-and-ceo-of-the-parker-institute-for-cancer-immunotherapy 2026-09-11T14:47:05.292Z https://www.parkerici.org/news/the-election-on-drugs 2026-09-11T14:47:05.317Z https://www.parkerici.org/news/facebook-and-napster-pioneer-to-start-cancer-immunotherapy-effort 2026-09-11T14:47:05.378Z https://www.parkerici.org/news/sean-parker-launches-an-unprecedented-cancer-research-effort 2026-09-11T14:47:05.346Z https://www.parkerici.org/news/sean-parker-is-giving-250-million-to-fight-cancer-with-new-immunotherapy-institute 2026-09-11T14:47:05.604Z https://www.parkerici.org/news/billionaire-announces-250-million-in-cancer-immunotherapy-funding 2026-09-11T14:47:05.630Z https://www.parkerici.org/news/250-million-300-scientists-and-40-labs-sean-parkers-revolutionary-project-to-solve-cancer 2026-09-11T14:47:05.640Z https://www.parkerici.org/news/sean-parker-just-gave-250m-to-the-darling-of-cancer-research 2026-09-11T14:47:05.660Z https://www.parkerici.org/news/silicon-valley-entrepreneur-launches-initiative-to-advance-cancer-immunotherapies 2026-09-11T14:47:05.681Z https://www.parkerici.org/news/sean-parker-sets-up-250-million-cancer-immunotherapy-collaboration 2026-09-11T14:47:05.688Z https://www.parkerici.org/news/sean-parker-gives-250-million-for-cancer-therapy-research 2026-09-11T14:47:05.860Z https://www.parkerici.org/news/sean-parkers-250-million-bet-on-hacking-the-immune-system-to-beat-cancer 2026-09-11T14:47:05.889Z https://www.parkerici.org/news/sean-parker-turns-to-cancer-research 2026-09-11T14:47:05.923Z https://www.parkerici.org/news/meet-the-big-names-behind-sean-parkers-cancer-immunotherapy-moonshot 2026-09-11T14:47:05.966Z https://www.parkerici.org/news/renowned-scientists-will-work-together-to-fight-cancer 2026-09-11T14:47:05.937Z https://www.parkerici.org/news/napster-co-founder-bankrolls-project-to-speed-cancer-work 2026-09-11T14:47:05.958Z https://www.parkerici.org/news/sean-parker-is-on-a-mission-to-solve-cancer 2026-09-11T14:47:06.129Z https://www.parkerici.org/news/entrepreneur-sean-parker-creates-cancer-immunotherapy-effort 2026-09-11T14:47:06.151Z https://www.parkerici.org/news/napster-founder-sean-parker-announces-250-million-grant-to-fight-cancer 2026-09-11T14:47:06.312Z https://www.parkerici.org/news/penn-joins-250m-cancer-research-alliance 2026-09-11T14:47:06.422Z https://www.parkerici.org/news/sean-parker-to-donate-250-million-to-cancer-immunotherapy-research 2026-09-11T14:47:06.217Z https://www.parkerici.org/news/inside-sean-parkers-250-million-bet-to-cure-cancer 2026-09-11T14:47:06.227Z https://www.parkerici.org/news/sean-parker-donates-250m-to-battle-cancer 2026-09-11T14:47:06.334Z https://www.parkerici.org/news/250-million-cancer-research-project-to-be-launched-in-us 2026-09-11T14:47:06.385Z https://www.parkerici.org/news/sean-parker-makes-record-250m-donation-to-cancer-immunotherapy 2026-09-11T14:47:06.516Z https://www.parkerici.org/news/sean-parker-puts-250m-into-new-cancer-immunotherapy-project 2026-09-11T14:47:06.473Z https://www.parkerici.org/news/tech-billionaire-sean-parker-funds-immunotherapy-cancer-institute-with-250-million 2026-09-11T14:47:06.545Z https://www.parkerici.org/news/napster-cofounder-sean-parker-donates-250-million-to-create-cancer-immunotherapy-institute 2026-09-11T14:47:06.603Z https://www.parkerici.org/news/with-250m-grant-sean-parker-launches-cancer-immunotherapy-institute 2026-09-11T14:47:06.643Z https://www.parkerici.org/news/tech-mogul-sean-parker-donates-250m-for-cancer-research 2026-09-11T14:47:06.661Z https://www.parkerici.org/news/billionaire-sean-parker-donates-250-mil-to-accelerate-breakthrough-cancer-immune-therapies 2026-09-11T14:47:06.830Z https://www.parkerici.org/news/tech-tycoons-250m-for-cancer-immunotherapy 2026-09-11T14:47:06.878Z https://www.parkerici.org/news/parker-foundation-launches-250m-collaborative-institute-for-cancer-immunotherapy 2026-09-11T14:47:06.827Z https://www.parkerici.org/news/sean-parkers-250-million-plan-to-annihilate-cancer 2026-09-11T14:47:06.854Z https://www.parkerici.org/news/billionaire-napster-founder-sean-parker-is-hacking-cancer-with-a-250-million-institute 2026-09-11T14:47:06.874Z https://www.parkerici.org/news/immunotherapy-to-cure-cancer-billionaire-sean-parker-launches-initiative 2026-09-11T14:47:06.897Z https://www.parkerici.org/news/vice-president-biden-provides-extensive-comments-about-the-collaborative-model-set-up-by-the-parker-institute 2026-09-11T14:50:08.362Z https://www.parkerici.org/news/can-sean-parker-hack-cancer 2026-09-11T14:50:08.245Z https://www.parkerici.org/news/nbc-dateline-on-assignment-hacking-cancer 2026-09-11T14:47:07.119Z https://www.parkerici.org/news/parker-institute-centers-share-updates-abstracts-at-asco-2016 2026-09-11T14:47:07.090Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-adds-key-leader-to-drive-clinical-research-efforts 2026-09-11T14:47:07.153Z https://www.parkerici.org/news/ucla-study-unlocks-key-mechanisms-that-determine-acquired-resistance-to-immunotherapy-in-advanced-melanoma 2026-09-11T14:47:07.137Z https://www.parkerici.org/news/harnessing-the-immune-system-to-fight-cancer 2026-09-11T14:47:07.265Z https://www.parkerici.org/news/jeff-bluestone-honored-as-a-2016-thomson-reuters-citation-laureate-jim-allison-of-md-anderson-cancer-center-and-craig-thompson-of-memorial-sloan-kettering-cancer-center-also-recognized 2026-09-11T14:47:07.305Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-aims-to-speed-up-cancer-research-trials-by-adopting-streamlined-review-process 2026-09-11T14:47:07.467Z https://www.parkerici.org/news/sean-parker-launches-the-parker-institute-for-cancer-immunotherapy 2026-09-11T14:47:07.447Z https://www.parkerici.org/news/the-parker-institute-for-cancer-immunotherapy-an-unprecedented-research-collaboration 2026-09-11T14:47:07.501Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-and-cancer-research-institute-launch-collaboration-on-cancer-neoantigens 2026-09-11T14:47:08.619Z https://www.parkerici.org/news/statement-by-the-parker-institute-for-cancer-immunotherapy-on-the-21st-century-cures-act 2026-09-11T14:47:07.703Z https://www.parkerici.org/news/algorithms-compete-to-predict-recipe-for-cancer-vaccine 2026-09-11T14:47:07.717Z https://www.parkerici.org/news/sean-parker-is-partnering-with-the-cancer-research-institute-to-find-a-cancer-vaccine 2026-09-11T14:47:07.711Z https://www.parkerici.org/news/breaking-down-silo-thinking 2026-09-11T14:47:07.735Z https://www.parkerici.org/news/seven-ucsf-scientists-receive-nih-blue-sky-research-awards 2026-09-11T14:47:07.814Z https://www.parkerici.org/news/friends-and-parker-institute-for-cancer-immunotherapy-co-host-summit-optimizing-the-use-of-immunotherapy 2026-09-11T14:47:07.987Z https://www.parkerici.org/news/ucsf-at-dreamforce-2016-watch-the-highlights 2026-09-11T14:47:07.963Z https://www.parkerici.org/news/culture-and-commerce-collide-at-the-third-vanity-fair-new-establishment-summit-in-san-francisco-this-october 2026-09-11T14:47:07.985Z https://www.parkerici.org/news/watch-full-panels-from-the-vanity-fair-new-establishment-summit-2016 2026-09-11T14:47:08.004Z https://www.parkerici.org/news/investigational-immunotherapy-safe-tolerable-shows-activity-against-melanoma 2026-09-11T14:47:08.131Z https://www.parkerici.org/news/the-iconoclast 2026-09-11T14:47:08.196Z https://www.parkerici.org/news/napster-founder-to-visit-penn-for-philly-launch-of-cancer-curing-initiative-he-funded-with-250-million 2026-09-11T14:47:08.282Z https://www.parkerici.org/news/tech-giant-sean-parker-launches-penns-cancer-immunotherapy-center 2026-09-11T14:47:08.252Z https://www.parkerici.org/news/three-win-school-of-medicines-highest-honor 2026-09-11T14:47:08.293Z https://www.parkerici.org/news/exploring-the-promise-and-challenges-of-cancer-immunotherapy 2026-09-11T14:47:08.485Z https://www.parkerici.org/news/sean-parker-this-is-how-tech-billionaires-do-philanthropy 2026-09-11T14:47:08.690Z https://www.parkerici.org/news/the-biggest-boldest-moments-at-our-brainstorm-health-conference 2026-09-11T14:47:08.657Z https://www.parkerici.org/news/fp-global-thinkers-2016-sean-parker-for-infusing-cancer-research-with-business-savvy 2026-09-11T14:47:08.644Z https://www.parkerici.org/news/the-parker-institute-for-cancer-immunotherapy-and-the-cancer-research-institute-announced-a-collaboration-focused-on-neoantigens 2026-09-11T14:47:08.692Z https://www.parkerici.org/news/the-biggest-science-stories-in-2016 2026-09-11T14:47:08.705Z https://www.parkerici.org/news/crispr-scientists-named-a-runner-up-for-times-person-of-the-year 2026-09-11T14:47:08.925Z https://www.parkerici.org/news/parker-institute-cancer-research-institute-team-up-on-neoantigen-based-cancer-vaccines 2026-09-11T14:47:09.029Z https://www.parkerici.org/news/sean-parkers-big-push-to-hack-cancer-takes-aim-at-tumor-tags 2026-09-11T14:47:08.959Z https://www.parkerici.org/news/sean-parkers-i-o-group-teams-up-with-cri-for-cancer-neoantigens-rd-deal 2026-09-11T14:47:08.935Z https://www.parkerici.org/news/hacking-a-personalized-cancer-vaccine 2026-09-11T14:47:09.018Z https://www.parkerici.org/news/parker-institutes-irb-reliance-agreement-signals-a-new-phase-in-the-trend-toward-consolidation 2026-09-11T14:47:08.971Z https://www.parkerici.org/news/the-emergence-of-philanthropy-to-fund-high-risk-high-reward-cancer-research-a-conversation-with-jeffrey-bluestone-phd 2026-09-11T14:47:09.191Z https://www.parkerici.org/news/kardashian-family-accepts-honor-for-late-father 2026-09-11T14:47:09.199Z https://www.parkerici.org/news/six-academic-centers-the-parker-institute-form-irb-reliance-agreement 2026-09-11T14:47:09.237Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-featured-in-the-cutting-edge-of-cancer-with-robin-roberts 2026-09-11T14:47:09.208Z https://www.parkerici.org/news/the-parker-institutes-shiny-new-irb-protocol 2026-09-11T14:47:09.278Z https://www.parkerici.org/news/the-parker-institute-aims-to-speed-up-cancer-rd-carving-out-duplicate-irbs-at-top-centers 2026-09-11T14:47:09.420Z https://www.parkerici.org/news/the-top-biotech-stories-of-2016 2026-09-11T14:47:09.394Z https://www.parkerici.org/news/a-new-kind-of-cancer-treatment-works-remarkably-well-for-some-patients-but-not-others-and-researchers-want-to-know-why 2026-09-11T14:47:09.411Z https://www.parkerici.org/news/eight-milestones-of-2016-in-the-war-on-cancer 2026-09-11T14:47:09.572Z https://www.parkerici.org/news/parker-institute-board-member-margaret-hamburg-named-president-elect-of-aaas 2026-09-11T14:47:09.607Z https://www.parkerici.org/news/inside-philanthropy-awards-2016 2026-09-11T14:50:08.196Z https://www.parkerici.org/news/a-radically-simple-idea-will-let-us-catch-cancer-before-its-cancer 2026-09-11T14:47:09.617Z https://www.parkerici.org/news/neon-therapeutics-bags-a-70m-round-for-early-stage-neoantigen-research 2026-09-11T14:47:09.629Z https://www.parkerici.org/news/1-japanese-2-americans-win-crafoord-science-prize 2026-09-11T14:47:09.938Z https://www.parkerici.org/news/sean-and-alexandra-parker-save-the-world 2026-09-11T14:47:09.867Z https://www.parkerici.org/news/t-cell-therapy-what-the-future-holds 2026-09-11T14:47:09.865Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-named-to-top-10-list-of-most-innovative-companies-in-biotech-by-fast-company 2026-09-11T14:47:09.852Z https://www.parkerici.org/news/all-antigens-are-not-created-equal-unique-tumor-mutations-called-neoantigens-could-hold-the-key-to-personalized-cancer-therapies 2026-09-11T14:47:09.913Z https://www.parkerici.org/news/jeff-bluestone-interviewed-on-cancer-immunotherapy 2026-09-11T14:47:09.912Z https://www.parkerici.org/news/the-problem-with-neoantigen-prediction 2026-09-11T14:47:10.147Z https://www.parkerici.org/news/the-double-edge-of-cancer-immunotherapy 2026-09-11T14:47:10.119Z https://www.parkerici.org/news/scientists-discover-why-some-cancers-may-not-respond-to-immunotherapy 2026-09-11T14:47:10.119Z https://www.parkerici.org/news/modified-donor-t-cells-may-decrease-risk-for-gvhd 2026-09-11T14:47:10.162Z https://www.parkerici.org/news/pillars-of-immunology 2026-09-11T14:47:10.156Z https://www.parkerici.org/news/gut-microbiome-a-player-in-response-to-anti-pd-1-cancer-immunotherapy 2026-09-11T14:47:10.253Z https://www.parkerici.org/news/there-could-be-a-surprising-link-between-how-people-respond-to-a-new-cancer-treatment-and-their-microbiome 2026-09-11T14:47:10.405Z https://www.parkerici.org/news/diverse-gut-microbiome-may-improve-response-to-immunotherapy-for-melanoma 2026-09-11T14:47:10.345Z https://www.parkerici.org/news/sean-and-alexandra-parker-gwyneth-paltrow-to-be-honored-at-ucla-mattel-childrens-hospital-event 2026-09-11T14:47:10.467Z https://www.parkerici.org/news/parker-institute-researchers-publish-first-major-scientific-paper-in-nature 2026-09-11T14:47:10.512Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-bristol-myers-squibb-and-the-cancer-research-institute-announce-collaboration-to-accelerate-immuno-oncology-research 2026-09-11T14:47:10.583Z https://www.parkerici.org/news/team-funded-by-billionaire-sean-parker-aims-to-be-first-to-use-crispr-gene-editing-in-people 2026-09-11T14:47:10.519Z https://www.parkerici.org/news/sean-parker-is-funding-the-first-human-trials-of-a-revolutionary-cancer-treatment 2026-09-11T14:47:10.651Z https://www.parkerici.org/news/a-sean-parker-backed-cancer-trial-that-would-use-crispr-in-humans-for-the-first-time-just-got-a-critical-approval 2026-09-11T14:47:10.748Z https://www.parkerici.org/news/money-behind-first-crispr-test-its-from-internet-billionaire-sean-parker 2026-09-11T14:47:10.800Z https://www.parkerici.org/news/first-crispr-clinical-trial-gets-green-light-from-us-panel 2026-09-11T14:47:10.881Z https://www.parkerici.org/news/personalized-tumor-vaccines-keep-cancer-in-check 2026-09-11T14:47:10.930Z https://www.parkerici.org/news/sean-parkers-cancer-project-claims-major-discovery-with-blood-tests 2026-09-11T14:47:10.941Z https://www.parkerici.org/news/funds-from-tech-guru-parker-speed-penn-study-of-skin-cancer 2026-09-11T14:47:10.966Z https://www.parkerici.org/news/sean-parkers-cancer-institute-may-have-found-a-blood-test-to-see-if-patients-will-respond-to-treatment 2026-09-11T14:47:11.008Z https://www.parkerici.org/news/american-association-for-cancer-research-announces-2017-class-of-fellows-of-the-aacr-academy 2026-09-11T14:47:11.020Z https://www.parkerici.org/news/bristol-myers-partners-with-parker-institute-cri-on-a-next-gen-twist-on-translational-rd 2026-09-11T14:47:11.166Z https://www.parkerici.org/news/bms-seeks-leg-up-in-immuno-oncology-with-parker-institute-and-cri-pact 2026-09-11T14:47:11.177Z https://www.parkerici.org/news/parker-institute-bms-and-cri-partner-on-immuno-oncology-research 2026-09-11T14:47:11.172Z https://www.parkerici.org/news/scientists-are-adopting-a-new-battle-plan-in-the-war-against-cancer 2026-09-11T14:47:11.197Z https://www.parkerici.org/news/parker-institute-marches-for-science 2026-09-11T14:47:11.228Z https://www.parkerici.org/news/autoimmunity-and-cancer-immunotherapy-perspective-piece-in-nature-medicine 2026-09-11T14:47:11.254Z https://www.parkerici.org/news/34-leaders-who-are-changing-health-care 2026-09-11T14:47:11.393Z https://www.parkerici.org/news/immunotherapy-pioneer-james-allison-has-unfinished-business-with-cancer 2026-09-11T14:47:11.417Z https://www.parkerici.org/news/it-will-take-an-army-to-kill-the-emperor 2026-09-11T14:47:11.445Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-scientists-to-present-research-at-asco-2017-on-ido-pathway-inhibitors-novel-car-ts-and-the-microbiomes-potential-in-immunotherapy 2026-09-11T14:47:11.438Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-bioinformatics-vice-president-nikesh-kotecha-to-speak-at-stanford-big-data-conference 2026-09-11T14:47:11.525Z https://www.parkerici.org/news/tessa-therapeutics-and-parker-institute-for-cancer-immunotherapy-enter-into-strategic-alliance-agreement 2026-09-11T14:47:11.539Z https://www.parkerici.org/news/the-parker-institute-for-cancer-immunotherapy-trains-the-next-generation-of-scientific-leaders-in-cancer-immunotherapy 2026-09-11T14:47:11.648Z https://www.parkerici.org/news/kronprinsessan-delar-ut-crafoordpriset-i-polyartrit-crown-princess-awards-crafoord-prize-in-polyarthritis 2026-09-11T14:47:11.653Z https://www.parkerici.org/news/the-tc-50-the-top-philanthropists-of-2017 2026-09-11T14:47:11.681Z https://www.parkerici.org/news/personalized-cancer-vaccines-look-promising-in-two-new-studies 2026-09-11T14:47:11.679Z https://www.parkerici.org/news/whats-up-with-sean-parkers-epic-quest-for-breakthroughs-on-cancer 2026-09-11T14:47:11.756Z https://www.parkerici.org/news/zipkin-flies-to-parker-institute 2026-09-11T14:47:11.802Z https://www.parkerici.org/news/grants-roundup 2026-09-11T14:47:11.843Z https://www.parkerici.org/news/tessa-therapeutics-parker-institute-partner-to-jointly-advance-research-in-cancer-immunotherapy 2026-09-11T14:47:11.853Z https://www.parkerici.org/news/bay-area-tech-titan-sean-parker-reaches-out-to-unheard-of-biotech-to-confront-immunotherapy 2026-09-11T14:47:11.896Z https://www.parkerici.org/news/parker-institute-tessa-in-cell-therapy-deal 2026-09-11T14:47:11.943Z https://www.parkerici.org/news/billionaire-backed-parker-institute-tackles-the-holy-grail-of-cancer-rd-with-a-virtual-unknown 2026-09-11T14:47:12.000Z https://www.parkerici.org/news/parker-tessa-alliance-tees-up-solid-tumor-i-o-combinations 2026-09-11T14:47:12.028Z https://www.parkerici.org/news/welcome-to-cellacon-valley 2026-09-11T14:47:12.035Z https://www.parkerici.org/news/the-bio-tech-bridge-how-tech-philanthropists-are-becoming-new-players-in-the-biotech-ecosystem 2026-09-11T14:47:12.087Z https://www.parkerici.org/news/back-asco-2017-higher-gut-bacteria-diversity-tied-to-slower-metastatic-melanoma-progression 2026-09-11T14:47:12.149Z https://www.parkerici.org/news/identifying-another-of-cancers-wily-tricks-masking-pain-so-tumors-can-grow-unnoticed 2026-09-11T14:47:12.191Z https://www.parkerici.org/news/io-kols-speak-on 2026-09-11T14:47:12.226Z https://www.parkerici.org/news/using-crispr-gene-editing-to-slow-cancer-growth 2026-09-11T14:47:12.473Z https://www.parkerici.org/news/personalized-cancer-neoantigen-vaccines-show-success-in-two-small-studies 2026-09-11T14:47:12.281Z https://www.parkerici.org/news/top-five-takeaways-from-asco-2017 2026-09-11T14:47:12.368Z https://www.parkerici.org/news/the-parker-institute-for-cancer-immunotherapy-and-the-cancer-research-institute-announce-first-patients-treated-in-pancreatic-cancer-clinical-trial-combining-immunotherapy-and-chemotherapy 2026-09-11T14:47:12.402Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-scientists-to-present-research-on-checkpoint-inhibitors-adoptive-cell-therapy-and-other-advances-in-immuno-oncology-at-aacr-2017 2026-09-11T14:47:12.431Z https://www.parkerici.org/news/glioblastoma-and-immunotherapy 2026-09-11T14:47:12.491Z https://www.parkerici.org/news/the-cancer-moonshot-and-parker-institute-for-cancer-immunotherapy 2026-09-11T14:47:12.573Z https://www.parkerici.org/news/neoantigen-based-personalized-immunotherapy-podcast 2026-09-11T14:47:12.631Z https://www.parkerici.org/news/meet-our-2017-parker-scholars-bridge-scholars-and-fellows 2026-09-11T14:47:12.700Z https://www.parkerici.org/news/from-leukemia-to-cancer-free-how-car-t-immunotherapy-saved-emily-whitehead 2026-09-11T14:47:12.713Z https://www.parkerici.org/news/ucla-study-shows-virus-plus-immunotherapy-hold-promise-for-advanced-melanoma 2026-09-11T14:47:12.736Z https://www.parkerici.org/news/novartis-kymriah-wins-fda-approval-as-first-car-t-cancer-therapy 2026-09-11T14:47:12.769Z https://www.parkerici.org/news/unleash-the-t-cells-enrolling-the-immune-system-in-the-fight-against-cancer-it-can-have-spectacular-results 2026-09-11T14:47:12.824Z https://www.parkerici.org/news/choosing-therapies-a-la-car-t-a-plethora-of-new-cancer-treatments-is-under-development-there-will-be-more-cures-and-they-will-be-expensive 2026-09-11T14:47:12.894Z https://www.parkerici.org/news/cancer-research-parker-institutes-to-test-i-o-combos-for-pancreatic-cancer 2026-09-11T14:47:12.932Z https://www.parkerici.org/news/sean-parker-institute-to-lead-immunotherapy-trial-for-pancreatic-cancer 2026-09-11T14:47:12.949Z https://www.parkerici.org/news/sean-parkers-cancer-fighting-institute-aims-1st-trial-at-tough-target 2026-09-11T14:47:13.023Z https://www.parkerici.org/news/dana-farber-cancer-institute-joins-the-parker-institute-for-cancer-immunotherapy 2026-09-11T14:47:13.025Z https://www.parkerici.org/news/dana-farber-researchers-join-parker-institute-for-cancer-immunotherapy 2026-09-11T14:47:13.140Z https://www.parkerici.org/news/body-heal-thyself 2026-09-11T14:47:13.140Z https://www.parkerici.org/news/sean-parkers-cancer-institute-keeps-growing-with-some-mind-blowing-new-research-projects 2026-09-11T14:47:13.185Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-researchers-present-findings-on-pancreatic-cancer-tumor-vaccines-and-car-t-at-2017-society-for-immunotherapy-of-cancer-annual-meeting 2026-09-11T14:47:13.206Z https://www.parkerici.org/news/future-research-priorities-in-the-usa-a-lancet-oncology-commission 2026-09-11T14:47:13.225Z https://www.parkerici.org/news/higher-diversity-of-gut-microbes-more-faecalibacteria-linked-to-better-response-to-cancer-immunotherapy-study-shows 2026-09-11T14:47:13.296Z https://www.parkerici.org/news/news-from-october-2017 2026-09-11T14:47:13.377Z https://www.parkerici.org/news/the-secret-to-cancer-treatment-may-be-in-our-guts 2026-09-11T14:47:13.377Z https://www.parkerici.org/news/decoding-the-secret-to-long-term-pancreatic-cancer-survival 2026-09-11T14:47:13.400Z https://www.parkerici.org/news/does-gut-flora-impact-the-response-to-cancer-immunotherapy 2026-09-11T14:47:13.406Z https://www.parkerici.org/news/seres-therapeutics-md-anderson-cancer-center-and-the-parker-institute-for-cancer-immunotherapy-announce-a-collaboration-to-support-the-investigation-of-microbiome-therapeutics-for-immuno-oncology 2026-09-11T14:47:13.477Z https://www.parkerici.org/news/sean-parker-awarded-sitc-2017-public-service-award 2026-09-11T14:47:13.531Z https://www.parkerici.org/news/parker-institute-md-anderson-and-seres-developing-a-microbiome-pd-1-l1-combo 2026-09-11T14:47:13.589Z https://www.parkerici.org/news/biotech-firms-race-to-recruit-good-bugs-in-war-on-cancer 2026-09-11T14:47:13.621Z https://www.parkerici.org/news/finding-a-way-for-the-right-microbiome-to-help-cancer-immunotherapy-work 2026-09-11T14:47:13.657Z https://www.parkerici.org/news/seres-md-anderson-parker-in-microbiome-immunotherapy-deal 2026-09-11T14:47:13.671Z https://www.parkerici.org/news/cd22-car-t-therapy-shows-results-in-leukemia-study-shows-but-could-a-dual-car-t-deliver-the-one-two-punch-to-avoid-relapse 2026-09-11T14:47:13.744Z https://www.parkerici.org/news/cnbc-launches-healthy-returns-a-conference-focusing-on-health-care-innovation 2026-09-11T14:47:13.826Z https://www.parkerici.org/news/how-the-microbiome-can-affect-cancer-treatments 2026-09-11T14:47:13.874Z https://www.parkerici.org/news/gut-bacteria-modulates-response-to-immunotherapy-in-melanoma 2026-09-11T14:47:13.872Z https://www.parkerici.org/news/a-novel-immuno-oncology-approach-to-treating-a-rare-childhood-brain-cancer 2026-09-11T14:47:13.898Z https://www.parkerici.org/news/we-are-hiring 2026-09-11T14:47:13.950Z https://www.parkerici.org/news/supercharging-philanthropy 2026-09-11T14:47:14.007Z https://www.parkerici.org/news/parker-institute-allied-tessa-grabs-an-80m-round-for-its-next-gen-cancer-cell-therapies 2026-09-11T14:47:14.083Z https://www.parkerici.org/news/calling-cancers-bluff-with-neoantigen-vaccines 2026-09-11T14:47:14.068Z https://www.parkerici.org/news/making-cancer-immunotherapy-a-surer-bet 2026-09-11T14:47:14.109Z https://www.parkerici.org/news/meet-the-scientist-who-helped-discover-a-class-of-potent-cancer-drugs 2026-09-11T14:47:14.165Z https://www.parkerici.org/news/the-nih-is-in-danger-of-losing-its-edge-in-creating-biomedical-innovations-oped-published-in-stat-news 2026-09-11T14:47:14.226Z https://www.parkerici.org/news/the-nih-is-in-danger-of-losing-its-edge-in-creating-biomedical-innovations 2026-09-11T14:47:14.294Z https://www.parkerici.org/news/new-cancer-treatments-have-perplexing-side-effects 2026-09-11T14:47:14.281Z https://www.parkerici.org/news/what-to-watch-in-science-this-year 2026-09-11T14:47:14.376Z https://www.parkerici.org/news/3-game-changing-biotechnologies-to-watch-in-2018 2026-09-11T14:47:14.372Z https://www.parkerici.org/news/inovio-and-parker-institute-to-collaborate-on-bladder-cancer-immunotherapies 2026-09-11T14:47:14.399Z https://www.parkerici.org/news/it-takes-guts-dr-jennifer-wargo 2026-09-11T14:47:14.487Z https://www.parkerici.org/news/how-the-parker-institute-uses-modern-data-science-to-solve-cancer 2026-09-11T14:47:14.542Z https://www.parkerici.org/news/the-parker-institute-applauds-the-senates-agreement-for-increased-nih-funding 2026-09-11T14:47:14.595Z https://www.parkerici.org/news/parker-institute-researchers-earn-awards-in-2017-and-2018 2026-09-11T14:47:14.604Z https://www.parkerici.org/news/cancer-and-the-microbiome-whats-old-is-new-again 2026-09-11T14:47:45.213Z https://www.parkerici.org/news/checking-out-the-microbiome 2026-09-11T14:47:45.223Z https://www.parkerici.org/news/predicting-childhood-leukemia-relapse-using-machine-learning 2026-09-11T14:47:45.214Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-scientist-kole-roybal-of-ucsf-wins-inaugural-sartorius-science-prize-for-regenerative-medicine-cell-therapy 2026-09-11T14:47:45.254Z https://www.parkerici.org/news/the-battle-to-tame-autoimmunity 2026-09-11T14:47:45.330Z https://www.parkerici.org/news/autoimmune-disease-treatments-focus-of-mcnair-symposium 2026-09-11T14:47:45.246Z https://www.parkerici.org/news/cell-therapy-for-cancer-past-present-and-future 2026-09-11T14:47:45.573Z https://www.parkerici.org/news/commentary-how-silicon-valley-can-help-fix-our-health-care-system 2026-09-11T14:47:45.431Z https://www.parkerici.org/news/could-immunotherapy-lead-the-way-to-fighting-cancer 2026-09-11T14:47:45.495Z https://www.parkerici.org/news/low-microbiota-diversity-linked-to-poor-survival-after-transplant 2026-09-11T14:47:45.542Z https://www.parkerici.org/news/too-much-of-a-good-thing 2026-09-11T14:47:45.589Z https://www.parkerici.org/news/piciturnstwo-2017-18-year-in-review 2026-09-11T14:47:45.673Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-scientists-to-present-immuno-oncology-research-on-personalized-cancer-vaccines-new-checkpoint-inhibitor-combinations-the-microbiome-and-cell-therapy-at-aacr 2026-09-11T14:47:45.717Z https://www.parkerici.org/news/how-gut-bacteria-impact-cancer-treatment-meet-the-stat-madness-2018-editors-pick 2026-09-11T14:47:45.755Z https://www.parkerici.org/news/personalized-cancer-vaccines-to-conquer-cancer 2026-09-11T14:47:45.732Z https://www.parkerici.org/news/a-new-personalized-vaccine-is-targeting-the-deadliest-cancers-in-america 2026-09-11T14:47:45.873Z https://www.parkerici.org/news/parker-institute-picks-from-aacr-2018-picipicks 2026-09-11T14:47:45.881Z https://www.parkerici.org/news/next-generation-of-leaders-gather-for-knowledge-exchange-in-cancer-immunotherapy-research 2026-09-11T14:47:45.939Z https://www.parkerici.org/news/neoadjuvant-pembrolizumab-appears-effective-for-resectable-melanoma 2026-09-11T14:47:45.936Z https://www.parkerici.org/news/fred-hutch-immunologist-dr-phil-greenberg-joins-parker-institute-for-cancer-immunotherapy 2026-09-11T14:47:46.015Z https://www.parkerici.org/news/using-medicine-and-science-to-improve-the-quality-of-life 2026-09-11T14:47:46.026Z https://www.parkerici.org/news/how-gut-microbes-are-joining-the-fight-against-cancer 2026-09-11T14:47:46.079Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-scientists-present-at-asco-2018-on-gene-editing-in-cell-therapy-novel-checkpoint-inhibitor-combinations-and-other-advances-in-immuno-oncology 2026-09-11T14:47:46.117Z https://www.parkerici.org/news/ido-donts-after-immunotherapy-failure-experts-say-slow-down 2026-09-11T14:47:46.148Z https://www.parkerici.org/news/trust-your-gut-the-microbiome-metastatic-melanoma 2026-09-11T14:47:46.182Z https://www.parkerici.org/news/colorectal-cancer-genetics-study-sheds-light-on-why-some-patients-are-resistant-to-treatment 2026-09-11T14:47:46.234Z https://www.parkerici.org/news/cancer-survivors-day-susan-schultz-picis-vp-of-business-operations 2026-09-11T14:47:46.354Z https://www.parkerici.org/news/for-james-allison-phd-perseverance-and-hard-science-are-paramount-in-cancer-research 2026-09-11T14:47:46.377Z https://www.parkerici.org/news/neoantigen-pioneer-neon-therapeutics-casts-off-in-search-of-115m-ipo-to-fuel-the-race-to-a-personalized-cancer-treatment 2026-09-11T14:47:46.669Z https://www.parkerici.org/news/pici-picks-for-asco-2018 2026-09-11T14:47:46.407Z https://www.parkerici.org/news/cd40-may-be-key-to-activating-immune-response-in-pancreatic-cancer 2026-09-11T14:47:46.457Z https://www.parkerici.org/news/reinventing-gene-editing-in-t-cells-to-fight-cancer 2026-09-11T14:47:46.637Z https://www.parkerici.org/news/with-new-genes-and-an-electric-shock-scientists-turn-immune-cells-against-cancer 2026-09-11T14:47:46.678Z https://www.parkerici.org/news/pici-scientist-at-dana-farber-cancer-institute-unravels-structure-of-key-cancer-detection-protein-in-immune-system 2026-09-11T14:47:46.764Z https://www.parkerici.org/news/swift-gene-editing-method-may-revolutionize-treatments-for-cancer-and-infectious-diseases 2026-09-11T14:47:46.771Z https://www.parkerici.org/news/removing-the-hidden-obstacle-holding-back-new-cancer-therapies 2026-09-11T14:47:46.811Z https://www.parkerici.org/news/parker-institute-scientists-herald-a-cell-therapy-breakthrough-in-the-lab-using-next-gen-crispr-tech-to-engineer-t-cells 2026-09-11T14:47:46.958Z https://www.parkerici.org/news/virus-free-crispr-could-mean-faster-more-precise-gene-editing-for-t-cell-therapies 2026-09-11T14:47:46.971Z https://www.parkerici.org/news/nonviral-crispr-technology-developed-for-faster-cheaper-t-cell-engineering 2026-09-11T14:47:46.990Z https://www.parkerici.org/news/a-parallel-universe-of-clinical-trials 2026-09-11T14:47:47.023Z https://www.parkerici.org/news/city-of-hopes-stephen-j-forman-joins-parker-institute-for-cancer-immunotherapy 2026-09-11T14:47:47.047Z https://www.parkerici.org/news/scientists-just-found-a-novel-cheap-way-to-use-crispr-gene-editing-to-fight-cancer 2026-09-11T14:47:47.116Z https://www.parkerici.org/news/faster-electric-gene-therapy-could-cure-diseases 2026-09-11T14:47:47.205Z https://www.parkerici.org/news/a-bubble-of-hope-for-cancer-the-exosome-in-immunotherapy 2026-09-11T14:47:47.204Z https://www.parkerici.org/news/car-t-pioneer-on-riding-the-nih-roller-coaster-speaking-up-for-science-and-his-funder-sean-parker 2026-09-11T14:47:47.227Z https://www.parkerici.org/news/why-dna-is-the-most-exciting-programming-language-today 2026-09-11T14:47:47.250Z https://www.parkerici.org/news/parker-institute-researchers-featured-at-fourth-international-immunotherapy-conference-2018-in-new-york-cicon18 2026-09-11T14:47:47.316Z https://www.parkerici.org/news/whats-new-in-immunotherapy 2026-09-11T14:47:47.302Z https://www.parkerici.org/news/james-allison-parker-institute-for-cancer-immunotherapy-director-wins-2018-nobel-prize-in-medicine-or-physiology-for-research-on-immune-checkpoint-inhibitors 2026-09-11T14:47:47.391Z https://www.parkerici.org/news/a-nobel-prize-for-jim-allison-and-tasuku-honjo-a-win-for-cancer-research 2026-09-11T14:47:47.412Z https://www.parkerici.org/news/cancer-rd-stars-jim-allison-tasuku-honjo-awarded-nobel-prize-for-immunotherapy-discoveries 2026-09-11T14:47:47.470Z https://www.parkerici.org/news/nobel-prize-for-medicine-goes-to-cancer-immune-therapy-pioneers 2026-09-11T14:47:47.489Z https://www.parkerici.org/news/the-parker-institute-for-cancer-immunotherapy-partners-with-xyphos-biosciences-to-develop-universal-programmable-car-t-cells-for-cancer-treatment 2026-09-11T14:47:47.503Z https://www.parkerici.org/news/could-probiotics-reduce-immunotherapys-chances-of-working-in-cancer-patients 2026-09-11T14:47:47.595Z https://www.parkerici.org/news/pici-sitc-2018-annual-meeting-sitc2018 2026-09-11T14:47:47.637Z https://www.parkerici.org/news/psioxus-therapeutics-to-collaborate-with-the-parker-institute-for-cancer-immunotherapy-on-virus-based-gene-therapy-to-treat-solid-tumors 2026-09-11T14:47:47.608Z https://www.parkerici.org/news/powering-personalized-immuno-oncology-big-datas-role 2026-09-11T14:47:47.685Z https://www.parkerici.org/news/silicon-valleys-tech-elite-zoom-in-on-crispr 2026-09-11T14:47:47.701Z https://www.parkerici.org/news/parker-institute-teams-up-with-xyphos-to-tame-car-ts 2026-09-11T14:47:47.700Z https://www.parkerici.org/news/19-at-least-of-time-magazines-50-most-influential-healthcare-people-have-biopharma-ties 2026-09-11T14:47:47.841Z https://www.parkerici.org/news/ucsd-moores-administers-its-first-personalized-cancer-vaccine 2026-09-11T14:47:47.879Z https://www.parkerici.org/news/forbes-400-list-sean-parker 2026-09-11T14:47:47.883Z https://www.parkerici.org/news/the-health-care-50-sean-parker-and-jim-allison 2026-09-11T14:47:47.903Z https://www.parkerici.org/news/parker-institute-and-xyphos-to-develop-universal-car-t-cell-therapies 2026-09-11T14:47:47.949Z https://www.parkerici.org/news/parker-institute-backs-an-upstart-biotech-looking-to-develop-a-new-convertible-car-t 2026-09-11T14:47:47.960Z https://www.parkerici.org/news/how-the-nobel-prize-could-spur-more-cancer-advances 2026-09-11T14:47:48.050Z https://www.parkerici.org/news/tech-how-sean-parker-is-working-to-build-a-clone-army-of-cancer-killing-assassins-for-patients 2026-09-11T14:47:48.095Z https://www.parkerici.org/news/news-of-note-psioxus-and-parker-institute-form-immuno-oncology-pact 2026-09-11T14:47:48.107Z https://www.parkerici.org/news/the-sandbox-parker-institute-throws-its-research-muscle-behind-gene-therapy-tech-for-destroying-cancer-cells 2026-09-11T14:47:48.102Z https://www.parkerici.org/news/after-the-pipette-using-clustering-to-unearth-insights-in-single-cell-data-video-tutorial 2026-09-11T14:47:48.147Z https://www.parkerici.org/news/immunotherapy-2-0-improving-the-response-to-checkpoint-inhibitors 2026-09-11T14:47:48.178Z https://www.parkerici.org/news/parker-backed-cancer-scientists-shine-a-light-on-an-emerging-pathway-in-pancreatic-cancer 2026-09-11T14:47:48.279Z https://www.parkerici.org/news/the-parker-institute-for-cancer-immunotherapy-expands-its-network-to-include-more-rising-stars-in-cancer-immunotherapy 2026-09-11T14:47:48.288Z https://www.parkerici.org/news/brain-cancer-breakthrough-with-immunotherapy-points-to-new-hope-for-patients 2026-09-11T14:47:48.318Z https://www.parkerici.org/news/billionaire-sean-parker-calls-chinas-gene-edited-babies-sputnik-2-0-praises-fda-and-offers-career-advice-for-millennials 2026-09-11T14:47:48.357Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-expands-valuable-network 2026-09-11T14:47:48.400Z https://www.parkerici.org/news/an-early-study-infuses-hope-back-into-attempts-to-use-immunotherapy-to-treat-brain-cancer 2026-09-11T14:47:48.401Z https://www.parkerici.org/news/keytruda-may-be-effective-in-helping-treat-brain-cancer 2026-09-11T14:47:48.553Z https://www.parkerici.org/news/how-turning-cold-tumors-into-hot-ones-may-improve-response-to-immunotherapy 2026-09-11T14:47:48.491Z https://www.parkerici.org/news/what-are-the-side-effects-of-immunotherapies-and-how-do-they-arise 2026-09-11T14:47:48.570Z https://www.parkerici.org/news/pici-president-and-ceo-jeffrey-bluestone-to-be-honored-with-the-aacr-irving-weinstein-foundation-distinguished-lectureship 2026-09-11T14:47:48.637Z https://www.parkerici.org/news/a-lot-has-happened-in-three-years-whats-going-on-with-the-parker-institute 2026-09-11T14:47:48.626Z https://www.parkerici.org/news/cracking-the-code-nikesh-kotecha 2026-09-11T14:47:48.715Z https://www.parkerici.org/news/new-study-suggests-diet-may-affect-response-to-cancer-immunotherapy-drugs 2026-09-11T14:47:48.753Z https://www.parkerici.org/news/high-fiber-diet-may-help-gut-microbiome-battle-melanoma 2026-09-11T14:47:48.801Z https://www.parkerici.org/news/a-new-wave-of-clinical-trials-in-immuno-oncology-collaborative-group-trials 2026-09-11T14:47:48.804Z https://www.parkerici.org/news/from-bench-to-bedside-dr-padmanee-sharma-talks-biomarkers-broken-arms-and-being-the-nobelle-of-the-ball 2026-09-11T14:47:48.870Z https://www.parkerici.org/news/a-single-dose-of-a-pd-1-inhibitor-before-surgery-may-predict-outcomes-in-patients-with-melanoma 2026-09-11T14:47:48.940Z https://www.parkerici.org/news/carl-june-md-how-he-developed-car-t-and-reflections-on-cell-therapy 2026-09-11T14:47:48.939Z https://www.parkerici.org/news/parker-institute-to-share-pancreatic-cancer-trial-results-microbiome-and-immunotherapy-research-and-new-car-t-approaches-at-aacr-2019 2026-09-11T14:47:49.031Z https://www.parkerici.org/news/probiotics-linked-to-poorer-response-to-cancer-immunotherapy-in-skin-cancer-patients 2026-09-11T14:47:49.044Z https://www.parkerici.org/news/for-advanced-pancreatic-cancer-combining-immunotherapies-with-chemotherapy-shows-early-promise-in-reducing-tumor-size 2026-09-11T14:47:49.141Z https://www.parkerici.org/news/after-a-33-year-odyssey-jeffrey-bluestone-grabs-a-ringside-seat-to-watch-his-drug-teplizumab-go-back-into-the-clinic 2026-09-11T14:47:49.159Z https://www.parkerici.org/news/the-parker-institute-touts-early-results-in-pancreatic-cancer-trial-and-a-new-model-to-accelerate-drug-development 2026-09-11T14:47:49.189Z https://www.parkerici.org/news/aacr-apexigen-bms-steal-the-show-with-promising-i-o-combo-in-pancreatic-cancer 2026-09-11T14:47:49.266Z https://www.parkerici.org/news/pancreatic-cancer-treatments-show-promise-in-studies-penn-reports 2026-09-11T14:47:49.300Z https://www.parkerici.org/news/despite-research-boom-few-immunotherapy-studies-targeting-pancreatic-cancer 2026-09-11T14:47:49.445Z https://www.parkerici.org/news/immunotherapy-chemotherapy-combination-shows-promising-antitumor-activity-in-metastatic-pancreatic-cancer 2026-09-11T14:47:49.432Z https://www.parkerici.org/news/researcher-comment-the-impact-of-lifestyle-factors-on-the-gut-microbiome-and-immunotherapy-response 2026-09-11T14:47:49.438Z https://www.parkerici.org/news/probiotics-poor-diet-may-interfere-with-cancer-immunotherapy 2026-09-11T14:47:49.569Z https://www.parkerici.org/news/probiotics-are-touted-as-good-for-the-gut-they-may-be-trouble-for-the-immune-system 2026-09-11T14:47:49.591Z https://www.parkerici.org/news/aacr-2019-roundup-notes-from-a-weekend-of-early-stage-cancer-results 2026-09-11T14:47:49.624Z https://www.parkerici.org/news/new-pancreatic-cancer-drug-regimen-shows-impressive-results-in-clinical-trial 2026-09-11T14:47:49.622Z https://www.parkerici.org/news/encouraging-antitumor-activity-in-pancreatic-ca-with-cd40-agonist 2026-09-11T14:47:49.666Z https://www.parkerici.org/news/pici-young-investigator-retreat-2019 2026-09-11T14:47:49.730Z https://www.parkerici.org/news/pici-picks-from-aacr-2019 2026-09-11T14:47:49.818Z https://www.parkerici.org/news/why-i-work-for-the-parker-institute 2026-09-11T14:47:49.842Z https://www.parkerici.org/news/vista-checkpoint-implicated-in-pancreatic-cancer-immunotherapy-resistance 2026-09-11T14:47:49.805Z https://www.parkerici.org/news/what-are-probiotics-5-things-you-need-to-know-about-them 2026-09-11T14:47:49.880Z https://www.parkerici.org/news/inspired-by-the-microbiome-can-poop-pills-and-gut-bugs-help-boost-cancer-immunotherapys-effects 2026-09-11T14:47:49.936Z https://www.parkerici.org/news/targeted-therapy-vaccines-car-t-and-a-practice-changer-at-aacr-2019 2026-09-11T14:47:49.979Z https://www.parkerici.org/news/the-priming-power-of-cdc2s 2026-09-11T14:47:49.983Z https://www.parkerici.org/news/smarter-bolder-cancer-immunotherapy-clinical-trials 2026-09-11T14:47:50.067Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-jdrf-and-the-helmsley-charitable-trust-form-cancer-and-diabetes-research-initiative 2026-09-11T14:47:50.110Z https://www.parkerici.org/news/anxious-lawyers-hindering-cutting-edge-drugs-scientists-say 2026-09-11T14:47:50.158Z https://www.parkerici.org/news/friends-parker-institute-call-for-more-flexibility-in-early-t-cell-therapy-development 2026-09-11T14:47:50.154Z https://www.parkerici.org/news/nec-becomes-the-first-japanese-company-to-join-the-tesla-consortiums-fight-against-cancer 2026-09-11T14:47:50.214Z https://www.parkerici.org/news/melanoma-investigators-strive-to-overcome-pd-1-inhibitor-resistance 2026-09-11T14:47:50.249Z https://www.parkerici.org/news/groups-seek-more-fda-flexibility-in-early-cell-therapy-development 2026-09-11T14:47:50.328Z https://www.parkerici.org/news/a-lifesaver-with-a-catch-powerful-new-cancer-drugs-can-trigger-diabetes-and-no-one-is-certain-why 2026-09-11T14:47:50.338Z https://www.parkerici.org/news/why-novartis-jay-bradner-thinks-car-t-needs-disruptive-innovation 2026-09-11T14:47:50.366Z https://www.parkerici.org/news/immunotherapy-is-fighting-cancer-but-leaving-1-of-patients-with-diabetes-and-scientists-have-no-idea-why 2026-09-11T14:47:50.359Z https://www.parkerici.org/news/diabetes-cancer-organizations-launch-10-million-research-effort 2026-09-11T14:47:50.404Z https://www.parkerici.org/news/groundbreaking-research-collaboration-to-study-immunotherapy-induced-diabetes 2026-09-11T14:47:50.443Z https://www.parkerici.org/news/researchers-identify-three-drug-combination-that-helps-curb-the-growth-of-deadly-type-of-skin-cancer 2026-09-11T14:47:50.554Z https://www.parkerici.org/news/billionaire-sean-parker-is-nerding-out-on-cancer-research-science-has-never-seen-anyone-quite-like-him 2026-09-11T14:47:50.562Z https://www.parkerici.org/news/the-parker-institute-looks-to-grow-leveraging-outside-donors-and-equity-stakes 2026-09-11T14:47:50.594Z https://www.parkerici.org/news/advice-on-charting-an-innovative-path-forward-for-cell-therapies 2026-09-11T14:47:50.578Z https://www.parkerici.org/news/cancer-research-institute 2026-09-11T14:47:50.655Z https://www.parkerici.org/news/where-cancer-killing-t-cells-come-from 2026-09-11T14:47:50.700Z https://www.parkerici.org/news/how-scientists-built-a-living-drug-to-beat-cancer 2026-09-11T14:50:08.158Z https://www.parkerici.org/news/improve-life-after-cancer-addressing-autoimmunity 2026-09-11T14:47:50.754Z https://www.parkerici.org/news/pici-biotrust-decodes-triple-negative-breast-cancer-in-tribute-collaboration 2026-09-11T14:47:50.803Z https://www.parkerici.org/news/informatics-accelerates-the-prince-pancreatic-cancer-clinical-trial 2026-09-11T14:47:50.881Z https://www.parkerici.org/news/note-from-picis-president-and-ceo-jeff-bluestone-introducing-our-new-brand 2026-09-11T14:47:50.900Z https://www.parkerici.org/news/research-initiative-aims-to-better-understand-link-between-immunotherapy-type-1-diabetes 2026-09-11T14:50:08.156Z https://www.parkerici.org/news/a-visionary-paving-the-way-for-faster-and-better-cancer-cures 2026-09-11T14:47:50.959Z https://www.parkerici.org/news/harnessing-the-power-of-microbes-to-fight-cancer 2026-09-11T14:50:08.217Z https://www.parkerici.org/news/parker-institutes-arsenalbio-launches-with-85m-to-build-cell-engineering-war-chest 2026-09-11T14:50:08.109Z https://www.parkerici.org/news/sean-parker-helps-create-a-crispred-cell-therapy-2-0-play-and-hes-got-a-high-profile-set-of-leaders-on-the-team 2026-09-11T14:50:08.004Z https://www.parkerici.org/news/sean-parker-billionaire-and-philanthropist-gets-an-immunotherapy-company-off-the-ground 2026-09-11T14:50:07.922Z https://www.parkerici.org/news/sean-parker-backed-arsenalbio-wants-to-create-better-weapons-against-cancer 2026-09-11T14:50:07.848Z https://www.parkerici.org/news/arsenalbio-joins-next-gen-cell-therapy-field-with-85m-a-round 2026-09-11T14:50:07.873Z https://www.parkerici.org/news/arsenalbio-launches-with-85m-for-programmable-t-cell-therapies 2026-09-11T14:50:07.786Z https://www.parkerici.org/news/parker-institute-spin-off-launches-to-make-crispr-edited-cell-therapies 2026-09-11T14:50:07.829Z https://www.parkerici.org/news/big-money-tech-science-back-startups-ambitious-cell-therapy-play 2026-09-11T14:50:07.803Z https://www.parkerici.org/news/arsenalbio-emerges-from-stealth-with-85-million-and-a-dream-team-to-fight-cancer 2026-09-11T14:50:07.740Z https://www.parkerici.org/news/arsenalbio-launches-with-28-million-series-a-to-develop-next-generation-immunotherapies 2026-09-11T14:50:07.607Z https://www.parkerici.org/news/arsenalbio-raises-85m-in-series-a-financing 2026-09-11T14:50:07.577Z https://www.parkerici.org/news/westlake-village-biopartners-takes-stake-in-cancer-therapy-startup 2026-09-11T14:50:07.581Z https://www.parkerici.org/news/pici-takes-on-prostate-cancer-a-qa-with-the-experts 2026-09-11T14:47:51.554Z https://www.parkerici.org/news/an-insider-view-of-picis-pancreatic-clinical-trial-prince 2026-09-11T14:47:51.619Z https://www.parkerici.org/news/how-gene-edited-white-blood-cells-are-helping-fight-cancer 2026-09-11T14:50:07.543Z https://www.parkerici.org/news/could-this-immuno-oncology-combo-treat-metastatic-prostate-cancer 2026-09-11T14:50:07.494Z https://www.parkerici.org/news/status-update-how-facebooks-billionaires-are-changing-the-world-of-philanthropy 2026-09-11T14:50:07.480Z https://www.parkerici.org/news/ucla-opens-clinical-trial-of-bispecific-car-t-cell-therapy-for-advanced-lymphoma-leukemia 2026-09-11T14:50:07.371Z https://www.parkerici.org/news/crispr-edited-t-cells-safely-effectively-target-cancer-cells-in-myeloma-patients-early-phase-1-data-suggests 2026-09-11T14:50:07.367Z https://www.parkerici.org/news/ash-upenns-crispr-edited-immune-cells-prove-safe-in-small-cancer-study 2026-09-11T14:50:07.357Z https://www.parkerici.org/news/doctors-use-crispr-to-fight-cancer-for-first-time-in-us 2026-09-11T14:50:07.316Z https://www.parkerici.org/news/early-results-from-first-in-u-s-trial-of-crispr-edited-immune-cells-for-cancer-patients-suggest-safety-of-approach 2026-09-11T14:50:07.173Z https://www.parkerici.org/news/gene-editing-tested-on-cancer-patients-for-first-time-in-u-s 2026-09-11T14:50:07.155Z https://www.parkerici.org/news/first-use-of-crispr-against-cancer-in-patients-clears-early-safety-hurdles 2026-09-11T14:50:07.155Z https://www.parkerici.org/news/doctors-use-crispr-gene-editing-against-cancer-for-the-1st-time-in-the-u-s 2026-09-11T14:50:07.129Z https://www.parkerici.org/news/doctors-try-crispr-gene-editing-for-cancer-a-1st-in-the-us 2026-09-11T14:50:07.043Z https://www.parkerici.org/news/doctors-use-crispr-gene-editing-in-cancer-patients-a-first-in-the-u-s 2026-09-11T14:50:06.978Z https://www.parkerici.org/news/crispr-takes-its-first-steps-in-editing-genes-to-fight-cancer 2026-09-11T14:50:06.974Z https://www.parkerici.org/news/crispr-approach-to-fighting-cancer-called-promising-in-1st-safety-test 2026-09-11T14:50:06.960Z https://www.parkerici.org/news/doctors-try-crispr-gene-editing-for-cancer-a-1st-in-the-us-2 2026-09-11T14:50:06.936Z https://www.parkerici.org/news/what-health-care-will-look-like-in-10-years-according-to-time 2026-09-11T14:50:06.911Z https://www.parkerici.org/news/12-innovations-that-will-change-health-care-and-medicine-in-the-2020s 2026-09-11T14:50:06.788Z https://www.parkerici.org/news/11253 2026-09-11T14:50:06.775Z https://www.parkerici.org/news/qa-the-parker-institutes-theresa-lavallee-on-the-path-forward-for-precision-immuno-oncology 2026-09-11T14:50:06.766Z https://www.parkerici.org/news/sean-parker-backed-startup-sees-data-driven-path-to-fight-cancer-2 2026-09-11T14:50:06.755Z https://www.parkerici.org/news/al-gore-on-impeachment-adam-silver-on-china-and-selma-blair-on-her-ms-diagnosis-here-are-biggest-moments-from-the-time-100-health-summit 2026-09-11T14:50:06.730Z https://www.parkerici.org/news/42nd-u-s-president-bill-clinton-to-join-the-time-100-health-summit-in-new-york-ny-on-october-17 2026-09-11T14:50:06.700Z https://www.parkerici.org/news/why-collaboration-and-innovation-are-key-to-improving-medical-research 2026-09-11T14:50:06.577Z https://www.parkerici.org/news/who-are-americas-most-and-least-generous-young-billionaires 2026-09-11T14:50:06.564Z https://www.parkerici.org/news/new-speakers-announced-for-the-first-ever-time-100-health-summit-on-october-17-in-new-york-ny 2026-09-11T14:50:06.555Z https://www.parkerici.org/news/time-100-health-summit 2026-09-11T14:50:06.510Z https://www.parkerici.org/news/an-interview-with-theresa-lavallee-parker-institute-for-cancer-immunotherapy 2026-09-11T14:50:06.515Z https://www.parkerici.org/news/celsius-therapeutics-to-use-single-cell-platform-in-three-new-immuno-oncology-collaborations 2026-09-11T14:50:06.457Z https://www.parkerici.org/news/close-to-a-decade-after-eli-lilly-killed-it-jeffrey-bluestones-breakthrough-drug-is-back-and-being-steered-to-the-fda 2026-09-11T14:50:06.370Z https://www.parkerici.org/news/pact-pharma-says-its-perfected-the-tech-to-select-neoantigens-for-personalized-therapy-now-onto-the-clinic 2026-09-11T14:50:06.373Z https://www.parkerici.org/news/pici-catalyzes-scientific-innovation 2026-09-11T14:47:52.793Z https://www.parkerici.org/news/top-10-immuno-oncology-startups-of-2019 2026-09-11T14:50:06.347Z https://www.parkerici.org/news/the-top-10-most-popular-endpoints-news-pieces-of-2019-going-viral-is-a-whole-new-game-in-biopharma-now 2026-09-11T14:50:06.256Z https://www.parkerici.org/news/innovation-in-biotech-rd-new-resources-offer-new-hope 2026-09-11T14:50:06.244Z https://www.parkerici.org/news/the-parker-institute-for-cancer-immunotherapy-awards-2-75-million-to-support-six-early-career-researchers-from-leading-research-institutions 2026-09-11T14:47:52.894Z https://www.parkerici.org/news/2019-annual-report 2026-09-11T14:47:52.932Z https://www.parkerici.org/news/crispr-edited-immune-cells-survive-for-months-and-still-kill-cancer 2026-09-11T14:50:06.194Z https://www.parkerici.org/news/june-lab-delivers-crispr-safety-message-in-cancer-clinical-trial 2026-09-11T14:50:06.155Z https://www.parkerici.org/news/crispr-edited-immune-cells-can-survive-and-thrive-after-infusion-into-cancer-patients 2026-09-11T14:50:06.169Z https://www.parkerici.org/news/a-message-from-pici-thank-you-to-those-addressing-this-global-pandemic 2026-09-11T14:47:53.104Z https://www.parkerici.org/news/an-immunologist-breaks-down-covid-19 2026-09-11T14:47:53.185Z https://www.parkerici.org/news/a-collaborative-effort-aims-to-change-the-future-of-patient-care-with-cancer-immunotherapy 2026-09-11T14:47:53.195Z https://www.parkerici.org/news/the-parker-institute-for-cancer-immunotherapy-awards-2-75-million-to-support-six-early-career-researchers 2026-09-11T14:50:06.065Z https://www.parkerici.org/news/pd1-resistance-with-a-multi-omic-approach 2026-09-11T14:50:06.017Z https://www.parkerici.org/news/the-parker-institute-for-cancer-immunotherapy-appoints-seasoned-health-care-leader-frederic-pla-as-chief-operating-officer 2026-09-11T14:47:53.289Z https://www.parkerici.org/news/frederic-pla-enlisted-as-coo-at-the-parker-institute-former-alkermes-exec-named-cmo-at-seres-therapeutics 2026-09-11T14:50:06.012Z https://www.parkerici.org/news/covid-19-reasons-for-hope-vaccine-trials-take-center-stage 2026-09-11T14:50:05.977Z https://www.parkerici.org/news/cprit-awards-19-6-million-to-md-anderson-sidney-kimmel-establishes-philadelphia-t-cell-lymphoma-leukemia-initiative-and-more 2026-09-11T14:50:05.920Z https://www.parkerici.org/news/the-power-of-patient-samples 2026-09-11T14:48:17.823Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-appoints-frederic-pla-phd-as-chief-operating-officer 2026-09-11T14:50:05.918Z https://www.parkerici.org/news/our-stance-on-equality 2026-09-11T14:48:17.785Z https://www.parkerici.org/news/early-memory-t-cell-population-may-predict-car-t-efficacy-in-several-hematological-malignancies 2026-09-11T14:50:05.794Z https://www.parkerici.org/news/a-science-driven-partnership-collaborating-for-cancer-cures 2026-09-11T14:48:17.832Z https://www.parkerici.org/news/how-can-we-use-the-microbiome-to-improve-cancer-immunotherapy-and-alleviate-side-effect-such-as-graft-versus-host-disease 2026-09-11T14:50:05.841Z https://www.parkerici.org/news/engineering-an-on-off-switch-for-car-t-out-of-yeast-and-jurassic-park 2026-09-11T14:50:05.811Z https://www.parkerici.org/news/the-parker-institute-for-cancer-immunotherapy-appoints-immunotherapy-expert-john-connolly-as-chief-scientific-officer 2026-09-11T14:48:18.095Z https://www.parkerici.org/news/turning-cancer-into-a-curable-disease-immunotherapy-expert-john-connolly-picks-up-the-reins-as-the-new-cso-of-sean-parkers-cancer-institute 2026-09-11T14:50:05.689Z https://www.parkerici.org/news/parker-institute-names-connolly-as-cso-targets-biopharma-pacts 2026-09-11T14:50:05.657Z https://www.parkerici.org/news/john-connolly-joins-the-parker-institute-as-chief-scientific-officer 2026-09-11T14:50:05.631Z https://www.parkerici.org/news/listen-how-immunity-works 2026-09-11T14:50:05.566Z https://www.parkerici.org/news/leaps-in-innovation-in-cancer-immunology-an-expert-panel-discussion 2026-09-11T14:50:05.589Z https://www.parkerici.org/news/covid-19-antibodies-may-fade-but-vaccine-hopes-have-not 2026-09-11T14:50:05.557Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-appoints-chief-scientific-officer 2026-09-11T14:50:05.436Z https://www.parkerici.org/news/io360-newsletter 2026-09-11T14:50:05.415Z https://www.parkerici.org/news/the-parker-institute-for-cancer-immunotherapy-appoints-john-connolly-phd-as-chief-scientific-officer 2026-09-11T14:50:05.390Z https://www.parkerici.org/news/climbing-towards-a-cure-for-cancer 2026-09-11T14:50:05.334Z https://www.parkerici.org/news/an-initiative-led-by-parker-institute-for-cancer-immunotherapy-and-cancer-research-institute-discovers-keys-that-could-unlock-better-personalized-treatments-to-destroy-cancer 2026-09-11T14:48:18.515Z https://www.parkerici.org/news/hematology-oncology-institutions-practices-announce-faculty-promotions-additions 2026-09-11T14:50:05.226Z https://www.parkerici.org/news/investing-in-people-the-power-and-promise-of-high-risk-science 2026-09-11T14:48:18.685Z https://www.parkerici.org/news/the-international-neoantigen-initiative-tumour-neoantigen-selection-alliance-tesla-has-identified-key-parameters-for-immunotherapy-advancement 2026-09-11T14:50:05.282Z https://www.parkerici.org/news/putting-ai-in-rd 2026-09-11T14:48:18.750Z https://www.parkerici.org/news/strength-in-numbers-identifying-neoantigen-targets-for-cancer-immunotherapy 2026-09-11T14:50:05.128Z https://www.parkerici.org/news/pandemic-inspires-impactful-public-private-partnerships 2026-09-11T14:48:18.789Z https://www.parkerici.org/news/nothing-can-replace-in-person-happy-hours-but-a-virtual-fun-retreat-comes-close 2026-09-11T14:48:18.854Z https://www.parkerici.org/news/tackling-pancreatic-cancer-with-a-triple-threat 2026-09-11T14:48:18.925Z https://www.parkerici.org/news/blood-test-could-predict-the-best-type-of-treatment-for-metastatic-melanoma 2026-09-11T14:48:18.986Z https://www.parkerici.org/news/a-legacy-of-service-how-one-womans-journey-could-help-bring-a-new-day-for-pancreatic-cancer-patients 2026-09-11T14:48:18.962Z https://www.parkerici.org/news/parker-institute-summoned-the-neoantigen-pioneers-to-compare-their-prediction-algorithms-and-they-have-some-suggestions-for-the-field 2026-09-11T14:48:19.011Z https://www.parkerici.org/news/cancer-vaccine-cocktail-boosts-immune-response-after-melanoma-surgery-research-shows 2026-09-11T14:48:19.066Z https://www.parkerici.org/news/highlights-of-2020-picis-progress-in-cancer-immunotherapy-and-beyond 2026-09-11T14:48:19.171Z https://www.parkerici.org/news/biomarker-predicts-poor-response-to-car-t-points-way-to-personalized-gene-edited-therapy 2026-09-11T14:50:05.106Z https://www.parkerici.org/news/breakthrough-cancer-therapies-offer-hope-for-patients 2026-09-11T14:48:19.224Z https://www.parkerici.org/news/gen-next-a-new-generation-of-entrepreneurial-and-innovative-donors-is-stepping-forward-to-carry-ucla-healths-rich-tradition-of-philanthropy-into-the-future 2026-09-11T14:48:19.245Z https://www.parkerici.org/news/seeking-solutions-for-deadly-brain-tumors-alliance-for-cancer-gene-therapy 2026-09-11T14:48:19.242Z https://www.parkerici.org/news/celebrating-women-leadership-in-immuno-oncology 2026-09-11T14:48:19.366Z https://www.parkerici.org/news/as-we-enter-2021-the-cancer-care-community-talks-about-what-the-future-holds 2026-09-11T14:50:05.056Z https://www.parkerici.org/news/fecal-matter-transplants-could-help-certain-cancer-drugs-work-in-more-people-study-shows 2026-09-11T14:50:05.025Z https://www.parkerici.org/news/ute-dugan-joins-the-parker-institute-for-cancer-immunotherapy-as-senior-vp-of-clinical-research 2026-09-11T14:48:19.471Z https://www.parkerici.org/news/ute-dugan-joins-the-parker-institute-for-cancer-immunotherapy-as-senior-vice-president-of-clinical-research 2026-09-11T14:50:04.985Z https://www.parkerici.org/news/improving-conventional-wisdom-from-car-t-therapy-to-diversity-in-stem-avery-posey-has-big-ideas 2026-09-11T14:48:19.478Z https://www.parkerici.org/news/funding-the-future-of-cancer-research-the-parker-institute-for-cancer-immunotherapy-awards-nearly-3-million-to-six-early-career-researchers 2026-09-11T14:48:19.605Z https://www.parkerici.org/news/oncologist-joins-parker-institute-for-cancer-immunotherapy-as-senior-vp-2 2026-09-11T14:50:05.000Z https://www.parkerici.org/news/https-www-healio-com-news-hematology-oncology-20210311-higher-disease-burden-leads-to-poorer-cart-outcomes-in-large-bcell-lymphoma 2026-09-11T14:50:04.888Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-awards-research-grants 2026-09-11T14:50:04.823Z https://www.parkerici.org/news/dr-ute-dugan-joins-parker-institute-for-cancer-immunotherapy 2026-09-11T14:50:04.817Z https://www.parkerici.org/news/parker-institute-appoints-ute-dugan-as-senior-vice-president-of-clinical-research 2026-09-11T14:50:04.800Z https://www.parkerici.org/news/1m-award-will-help-expand-covid-19-treatment-database 2026-09-11T14:50:04.813Z https://www.parkerici.org/news/searching-the-blood-for-signs-of-altered-immunity 2026-09-11T14:50:04.686Z https://www.parkerici.org/news/new-car-t-approach-could-overcome-resistance-avoid-relapse-in-some-cancer-patients 2026-09-11T14:48:20.010Z https://www.parkerici.org/news/five-years-of-transforming-cancer-immunotherapy-research-five-promises-kept 2026-09-11T14:48:20.003Z https://www.parkerici.org/news/making-a-more-durable-car-t 2026-09-11T14:50:04.635Z https://www.parkerici.org/news/product-composition-immune-biomarkers-linked-to-car-t-efficacy 2026-09-11T14:50:04.594Z https://www.parkerici.org/news/tumor-infiltrating-lymphocytes-show-provocative-response-rates-in-advanced-melanoma 2026-09-11T14:50:04.574Z https://www.parkerici.org/news/glowing-tumor-munching-cells-captured-on-video-show-the-promise-of-a-new-approach-to-car-t-cancer-therapy 2026-09-11T14:50:04.584Z https://www.parkerici.org/news/pici-announces-partnership-with-the-v-foundation-to-co-fund-grants 2026-09-11T14:48:20.279Z https://www.parkerici.org/news/empowering-pancreatic-cancer-patients-and-delivering-innovative-immunotherapies-1440-foundation 2026-09-11T14:48:20.247Z https://www.parkerici.org/news/pici-makes-progress-in-toughest-tumor-types-with-pancreatic-cancer-combo-immune-activity-in-cold-tumors 2026-09-11T14:48:20.351Z https://www.parkerici.org/news/when-cancer-becomes-a-calling 2026-09-11T14:48:20.315Z https://www.parkerici.org/news/car-t-with-synthetic-binder-shows-very-promising-results-in-advanced-multiple-myeloma 2026-09-11T14:50:04.538Z https://www.parkerici.org/news/gene-edited-t-cell-therapy-shows-promising-efficacy-for-rare-sarcomas 2026-09-11T14:50:04.439Z https://www.parkerici.org/news/five-key-takeaways-from-the-2021-asco-annual-meeting 2026-09-11T14:48:20.519Z https://www.parkerici.org/news/nanostring-and-parker-institute-for-cancer-immunotherapy-collaborate-to-optimize-cell-therapies-to-treat-cancer 2026-09-11T14:48:20.588Z https://www.parkerici.org/news/immunotherapy-options-around-the-bend 2026-09-11T14:50:04.422Z https://www.parkerici.org/news/nanostring-and-parker-institute-for-cancer-immunotherapy-collaborate-to-optimize-cell-therapies-to-treat-cancer-2 2026-09-11T14:50:04.377Z https://www.parkerici.org/news/nanostring-technologies-parker-institute-for-cancer-immunotherapy-partner-on-cell-therapy-project 2026-09-11T14:50:04.376Z https://www.parkerici.org/news/all-the-right-ingredients-a-qa-with-the-founders-of-arsenalbio 2026-09-11T14:48:20.966Z https://www.parkerici.org/news/sean-parker-backed-cell-therapy-startup-arsenalbio-plucks-merck-vp-as-new-cso 2026-09-11T14:50:04.385Z https://www.parkerici.org/news/a-cure-for-cancer-immunotherapy-could-be-the-key 2026-09-11T14:50:04.307Z https://www.parkerici.org/news/v-foundation-wine-celebration-raises-millions-to-support-cancer-research 2026-09-11T14:50:04.190Z https://www.parkerici.org/news/crispr-gene-editing-may-put-universal-t-cell-therapy-within-reach 2026-09-11T14:50:04.179Z https://www.parkerici.org/news/connecting-pancreatic-cancer-patients-with-innovative-immunotherapies-pici-and-1440-foundation 2026-09-11T14:48:21.004Z https://www.parkerici.org/news/the-parker-institute-for-cancer-immunotherapy-and-the-cancer-research-institute-announce-first-patients-dosed-in-first-line-pancreatic-cancer-platform-trial 2026-09-11T14:48:21.201Z https://www.parkerici.org/news/project-aims-to-improve-cancer-cell-therapies-through-gene-expression-profiling 2026-09-11T14:50:04.151Z https://www.parkerici.org/news/biomarkers-may-predict-better-immunotherapy-treatment-outcomes-for-certain-patients-with-pancreatic-cancer 2026-09-11T14:48:21.173Z https://www.parkerici.org/news/five-year-collaboration-aims-to-fund-and-spin-out-new-companies-based-on-discoveries-from-picis-network-of-world-leading-researchers-and-with-access-to-resiliences-biomanufacturing-t 2026-09-11T14:48:21.267Z https://www.parkerici.org/news/resilience-a-well-funded-manufacturing-startup-joins-with-the-parker-institute-to-make-cancer-drugs 2026-09-11T14:50:04.173Z https://www.parkerici.org/news/three-arm-first-line-chemoimmunotherapy-study-in-patients-with-metastatic-pancreatic-cancer 2026-09-11T14:50:04.147Z https://www.parkerici.org/news/resilience-a-well-funded-manufacturing-startup-joins-with-the-parker-institute-to-make-cancer-drugs-2 2026-09-11T14:50:04.077Z https://www.parkerici.org/news/resilience-a-well-funded-manufacturing-startup-joins-with-the-parker-institute-to-make-cancer-drugs-3 2026-09-11T14:50:03.976Z https://www.parkerici.org/news/resilience-a-well-funded-manufacturing-startup-joins-with-the-parker-institute-to-make-cancer-drugs-4 2026-09-11T14:50:03.973Z https://www.parkerici.org/news/ecr22 2026-09-11T14:48:21.475Z https://www.parkerici.org/news/lumabridge 2026-09-11T14:48:21.516Z https://www.parkerici.org/news/pici-network-researchers-featured-at-cancer-research-uk-brain-tumour-conference-crukbrain22 2026-09-11T14:48:21.591Z https://www.parkerici.org/news/esmo22 2026-09-11T14:48:21.649Z https://www.parkerici.org/news/aacrpan22 2026-09-11T14:48:21.663Z https://www.parkerici.org/news/cicon22 2026-09-11T14:48:21.736Z https://www.parkerici.org/news/pici-welcomes-dana-farber-and-gladstone-institutes 2026-09-11T14:48:21.831Z https://www.parkerici.org/news/sitc22 2026-10-06T14:53:14.804Z https://www.parkerici.org/news/ash22 2026-09-11T14:48:21.878Z https://www.parkerici.org/news/2022-2 2026-09-11T14:48:21.932Z https://www.parkerici.org/news/kscelltherapy23 2026-09-11T14:48:22.118Z https://www.parkerici.org/news/kscancerimmuno23 2026-09-11T14:48:22.187Z https://www.parkerici.org/news/pici-to-honor-dr-carl-h-june-md 2026-09-11T14:48:22.140Z https://www.parkerici.org/news/pici-network-researchers-to-present-at-sitc-spring-scientific 2026-09-11T14:48:22.140Z https://www.parkerici.org/news/pici-celebrates-carl-h-june-md 2026-09-11T14:48:22.164Z https://www.parkerici.org/news/aacr23 2026-09-11T14:48:22.243Z https://www.parkerici.org/news/guardant-health 2026-09-11T14:48:22.380Z https://www.parkerici.org/news/asco23 2026-09-11T14:48:22.364Z https://www.parkerici.org/news/ecr23 2026-09-11T14:48:22.442Z https://www.parkerici.org/news/io23asgct 2026-09-11T14:48:22.439Z https://www.parkerici.org/news/cartcr23 2026-09-11T14:48:22.552Z https://www.parkerici.org/news/new-staffers 2026-09-11T14:48:22.619Z https://www.parkerici.org/news/aacrtii23 2026-09-11T14:48:22.589Z https://www.parkerici.org/news/pici-welcomes-new-ucsf-center-director 2026-09-11T14:48:22.641Z https://www.parkerici.org/news/sitc23 2026-09-11T14:48:22.827Z https://www.parkerici.org/news/introducing-from-bench-to-fireside 2026-09-11T14:48:22.811Z https://www.parkerici.org/news/from-bench-to-fireside-episode-one 2026-09-11T14:48:22.803Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-pici-welcomes-weill-cornell-medicine-to-cancer-research-consortium 2026-09-11T14:48:22.851Z https://www.parkerici.org/news/from-bench-to-fireside-episode-two 2026-09-11T14:48:24.186Z https://www.parkerici.org/news/year-in-review-picis-progress-in-2023 2026-09-11T14:48:23.116Z https://www.parkerici.org/news/from-bench-to-fireside-episode-three 2026-09-11T14:48:23.109Z https://www.parkerici.org/news/from-bench-to-fireside-episode-four 2026-09-11T14:48:23.097Z https://www.parkerici.org/news/from-bench-to-fireside-episode-five 2026-09-11T14:48:23.155Z https://www.parkerici.org/news/from-bench-to-fireside-episode-six 2026-09-11T14:48:23.185Z https://www.parkerici.org/news/from-bench-to-fireside-episode-seven 2026-09-11T14:48:23.399Z https://www.parkerici.org/news/from-bench-to-fireside-episode-eight-2 2026-09-11T14:48:23.417Z https://www.parkerici.org/news/pici-network-investigators-to-unveil-cancer-research-breakthroughs-at-aacr-2024 2026-09-11T14:48:23.428Z https://www.parkerici.org/news/from-bench-to-fireside-episode-nine-2 2026-09-11T14:48:23.476Z https://www.parkerici.org/news/bostongene-and-the-parker-institute-for-cancer-immunotherapy-collaborate-to-generate-comprehensive-longitudinal-multi-omic-data-for-predicting-immunotherapy-outcomes 2026-09-11T14:48:23.524Z https://www.parkerici.org/news/pici-hosts-2024-spring-scientific-retreat 2026-09-11T14:48:23.738Z https://www.parkerici.org/news/unlocking-complex-cell-based-gene-therapies-a-joint-workshop-hosted-by-pici-and-focr 2026-09-11T14:48:24.825Z https://www.parkerici.org/news/pici-network-investigators-to-showcase-immunotherapy-advances-at-asco-2024 2026-09-11T14:48:23.798Z https://www.parkerici.org/news/behind-the-breakthrough-an-interview-with-carl-june-the-father-of-car-t-cell-therapy 2026-09-11T14:48:23.834Z https://www.parkerici.org/news/the-parker-institute-for-cancer-immunotherapy-awards-more-than-1-million-to-four-early-career-investigators 2026-09-11T14:48:23.898Z https://www.parkerici.org/news/parker-institute-commits-additional-125m-for-audacious-mission-to-cure-cancer 2026-09-11T14:48:24.080Z https://www.parkerici.org/news/parker-institute-welcomes-new-co-directors-for-pici-centers-at-stanford-ucsf-penn 2026-09-11T14:48:24.134Z https://www.parkerici.org/news/pici-hosts-2024-fall-scientific-retreat 2026-09-11T14:48:24.192Z https://www.parkerici.org/news/pici-network-investigators-propel-immunotherapy-progress-at-sitc-2024 2026-10-06T14:38:49.500Z https://www.parkerici.org/news/parker-institute-awards-525000-to-advance-talent-in-cancer-research 2026-09-11T14:48:25.355Z https://www.parkerici.org/news/pici-2024-collaborative-breakthroughs-in-cancer-immunotherapy 2026-09-11T14:48:24.467Z https://www.parkerici.org/news/from-car-t-cell-therapy-to-the-impact-of-mentorship-with-carl-june-md 2026-09-11T14:48:24.575Z https://www.parkerici.org/news/from-the-front-lines-to-the-frontiers-of-defeating-breast-cancer-with-elizabeth-mittendorf-md-phd 2026-09-11T14:48:24.744Z https://www.parkerici.org/news/from-metastatic-melanoma-to-immune-engineering-with-antoni-ribas-md-phd 2026-09-11T14:48:24.808Z https://www.parkerici.org/news/owen-witte-co-director-of-pici-at-ucla-awarded-international-harrington-prize-for-innovation-in-medicine 2026-09-11T14:50:03.899Z https://www.parkerici.org/news/cell-therapy-shows-promise-against-deadly-childhood-brain-cancer-in-trial-led-by-crystal-mackall-and-michelle-monje 2026-09-11T14:50:03.909Z https://www.parkerici.org/news/penn-renews-pici-membership-securing-share-of-125-million-grant 2026-09-11T14:50:03.885Z https://www.parkerici.org/news/penn-pici-renew-research-collaboration 2026-09-11T14:50:03.857Z https://www.parkerici.org/news/pici-funding-boosts-cancer-immunotherapy-research 2026-09-11T14:50:03.749Z https://www.parkerici.org/news/pici-invests-another-125m-to-fund-cancer-cures 2026-09-11T14:50:03.698Z https://www.parkerici.org/news/pici-distributes-another-125-million-in-research-grants 2026-09-11T14:50:03.679Z https://www.parkerici.org/news/pici-expands-investment-in-immunotherapy-research 2026-09-11T14:50:03.637Z https://www.parkerici.org/news/study-by-carl-june-pici-center-director-at-penn-medicine-finds-no-link-between-car-t-and-secondary-cancers 2026-09-11T14:50:03.649Z https://www.parkerici.org/news/boston-gene-pici-form-research-collaboration 2026-09-11T14:50:03.550Z https://www.parkerici.org/news/breakthrough-prize-for-car-t-research-awarded-to-carl-june-center-director-of-pici-at-penn-medicine 2026-09-11T14:50:03.437Z https://www.parkerici.org/news/cancer-vaccine-study-shows-early-promise-in-science-translational-medicine 2026-09-11T14:50:03.412Z https://www.parkerici.org/news/carl-june-on-the-next-biotech-breakthroughs-and-why-philadelphia-is-poised-to-lead 2026-09-11T14:50:03.338Z https://www.parkerici.org/news/pici-expands-to-gladstone-institutes-dana-farber-cancer-institute 2026-09-11T14:50:03.240Z https://www.parkerici.org/news/pici-grows-network-with-new-center-at-weill-cornell-medicine 2026-09-11T14:50:03.248Z https://www.parkerici.org/news/carl-june-pici-center-director-at-penn-medicine-recieves-2024-breakthrough-prize-in-life-sciences 2026-09-11T14:50:03.286Z https://www.parkerici.org/news/pici-guardant-health-partner-on-immunotherapy-study 2026-09-11T14:50:03.185Z https://www.parkerici.org/news/carl-june-pici-center-director-at-penn-medicine-receives-aacr-lifetime-achievement-award-in-cancer-research 2026-09-11T14:50:03.212Z https://www.parkerici.org/news/pancreatic-cancer-models-show-unprecedented-response-in-nature-cancer-study 2026-09-11T14:50:03.007Z https://www.parkerici.org/news/pici-adds-dana-farber-gladstone-institutes-to-cancer-research-collaboration 2026-09-11T14:50:03.019Z https://www.parkerici.org/news/lumabridge-and-pici-partner-to-accelerate-cancer-immunotherapy-development 2026-09-11T14:50:03.035Z https://www.parkerici.org/news/pici-invests-4-5-million-in-the-next-generation-of-cancer-immunotherapy-scientists 2026-09-11T14:50:02.974Z https://www.parkerici.org/news/karen-knudsen-mba-phd-appointed-chief-executive-officer-of-the-parker-institute-for-cancer-immunotherapy 2026-09-11T14:48:26.433Z https://www.parkerici.org/news/parker-institute-appoints-renowned-cancer-immunologist-dr-ira-mellman-as-president-of-research 2026-09-11T14:48:26.573Z https://www.parkerici.org/news/pici-at-aacr-2025 2026-09-11T14:48:26.630Z https://www.parkerici.org/news/immunai-and-the-parker-institute-collaborate-to-build-one-of-the-largest-single-cell-datasets-in-cancer 2026-09-11T14:48:26.600Z https://www.parkerici.org/news/lumanity-to-support-translation-of-picis-breakthrough-science-with-go-to-market-expertise 2026-09-11T14:48:26.576Z https://www.parkerici.org/news/asco2025 2026-09-11T14:48:26.791Z https://www.parkerici.org/news/designing-whats-next-picis-2025-springscientific-retreat 2026-09-11T14:48:26.814Z https://www.parkerici.org/news/dr-karen-knudsen-named-to-cnbcs-2025-changemakers-list 2026-09-11T14:48:26.936Z https://www.parkerici.org/news/cnbc-honors-pici-ceo-for-transformative-leadership 2026-09-11T14:50:03.000Z https://www.parkerici.org/news/pici-launches-dispatch-bio-to-combat-solid-tumors 2026-09-11T14:48:26.991Z https://www.parkerici.org/news/the-parker-institute-for-cancer-immunotherapy-awards-over-1-million-to-five-early-stage-career-researchers-pushing-the-boundaries-of-cancer-science 2026-09-11T14:48:27.060Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-demonstrates-leadership-and-showcases-latest-advances-in-immunotherapy-at-sitc-2025-annual-meeting 2026-10-05T19:57:23.293Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-announces-appointment-of-mark-veich-as-chief-organizational-advancement-officer 2026-09-11T14:48:27.266Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-collaborates-with-conquer-cancer-and-asco-to-support-promising-cancer-research 2026-09-29T15:47:06.240Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-announces-appointment-of-bob-purcell-as-chief-communications-officer 2026-09-29T15:45:43.289Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-appoints-bolyn-hubby-as-chief-of-staff 2026-09-11T14:48:27.335Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-and-cancer-vaccine-coalition-unite-to-accelerate-cancer-prevention-and-treatment-as-momentum-builds-for-cancer-vaccines 2026-09-29T15:37:42.043Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-shapes-the-future-of-immunotherapy-with-latest-research-at-aacr-annual-aeeting-2026 2026-09-29T15:36:07.530Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-announces-appointment-of-aimee-johnson-as-chief-marketing-officer 2026-09-29T15:34:06.892Z https://www.parkerici.org/news/parker-institute-for-cancer-immunotherapy-brings-power-of-integrated-network-to-asco-2026 2026-09-24T22:00:37.439Z https://www.parkerici.org/news/dr-rebecca-a-sager-named-recipient-of-picis-inaugural-endowed-young-investigator-award 2026-09-24T21:58:28.460Z https://www.parkerici.org/news/cancer-vaccines-a-new-era-in-cancer-treatment 2026-09-11T14:48:27.570Z https://www.parkerici.org/news/living-proof-cancer-vaccine-recipients-bring-their-stories-to-capitol-hill 2026-09-23T19:42:57.730Z https://www.parkerici.org/news/pici-invests-more-than-1-million-in-five-early-career-researchers 2026-09-25T14:35:15.405Z https://www.parkerici.org/our-model/published-research/visualizing-synaptic-transfer-of-tumor-antigens-among-dendritic-cells 2026-09-28T20:50:07.249Z https://www.parkerici.org/our-model/published-research/nivolumab-plus-ipilimumab-in-lung-cancer-with-a-high-tumor-mutational-burden 2026-09-07T15:32:14.433Z https://www.parkerici.org/our-model/published-research/epigenomic-guided-mass-cytometry-profiling-reveals-disease-specific-features-of-exhausted-cd8-t-cells 2026-09-07T15:32:16.017Z https://www.parkerici.org/our-model/published-research/selective-targeting-of-engineered-t-cells-using-orthogonal-il-2-cytokine-receptor-complexes 2026-09-07T15:32:16.505Z https://www.parkerici.org/our-model/published-research/transcript-indexed-atac-seq-for-precision-immune-profiling 2026-09-07T15:32:16.945Z https://www.parkerici.org/our-model/published-research/genetic-mechanisms-of-immune-evasion-in-colorectal-cancer 2026-09-07T15:32:17.381Z https://www.parkerici.org/our-model/published-research/t-cells-genetically-engineered-to-overcome-death-signaling-enhance-adoptive-cancer-immunotherapy 2026-09-07T15:32:17.812Z https://www.parkerici.org/our-model/published-research/neoadjuvant-anti-pd-1-immunotherapy-promotes-a-survival-benefit-with-intratumoral-and-systemic-immune-responses-in-recurrent-glioblastoma 2026-09-07T15:32:18.247Z https://www.parkerici.org/our-model/published-research/neoadjuvant-immune-checkpoint-blockade-in-high-risk-resectable-melanoma 2026-09-07T15:32:18.708Z https://www.parkerici.org/our-model/published-research/multiplex-single-cell-tracing-across-time-and-division-states-enables-control-of-t-cell-differentiation 2026-09-07T15:32:19.142Z https://www.parkerici.org/our-model/published-research/high-dimensional-analysis-delineates-myeloid-and-lymphoid-compartment-remodeling-during-successful-immune-checkpoint-cancer-therapy 2026-09-07T15:32:19.569Z https://www.parkerici.org/our-model/published-research/defining-t-cell-states-associated-with-response-to-checkpoint-immunotherapy-in-melanoma 2026-09-07T15:32:20.025Z https://www.parkerici.org/our-model/published-research/genome-wide-crispr-screens-in-primary-human-t-cells-reveal-key-regulators-of-immune-function 2026-09-07T15:32:20.480Z https://www.parkerici.org/our-model/published-research/a-structured-tumor-immune-microenvironment-in-triple-negative-breast-cancer-revealed-by-multiplexed-ion-beam-imaging 2026-09-07T15:32:20.905Z https://www.parkerici.org/our-model/published-research/impact-of-baseline-steroids-on-efficacy-of-programmed-cell-death-1-and-programmed-death-ligand-1-blockade-in-patients-with-non-small-cell-lung-cancer 2026-09-07T15:32:21.305Z https://www.parkerici.org/our-model/published-research/reprogramming-human-t-cell-function-and-specificity-with-non-viral-genome-targeting 2026-09-07T15:32:21.726Z https://www.parkerici.org/our-model/published-research/five-year-survival-with-combined-nivolumab-and-ipilimumab-in-advanced-melanoma 2026-09-07T15:32:22.168Z https://www.parkerici.org/our-model/published-research/mhc-ii-neoantigens-shape-tumour-immunity-and-response-to-immunotherapy 2026-09-07T15:32:22.618Z https://www.parkerici.org/our-model/published-research/b-cells-and-tertiary-lymphoid-structures-promote-immunotherapy-response 2026-09-07T15:32:23.067Z https://www.parkerici.org/our-model/published-research/ilc2s-amplify-pd-1-blockade-by-activating-tissue-specific-cancer-immunity 2026-09-07T15:32:23.493Z https://www.parkerici.org/our-model/published-research/crispr-engineered-t-cells-in-patients-with-refractory-cancer 2026-09-07T15:32:23.918Z https://www.parkerici.org/our-model/published-research/pooled-knockin-targeting-for-genome-engineering-of-cellular-immunotherapies 2026-09-07T15:32:24.369Z https://www.parkerici.org/our-model/published-research/locoregionally-administered-b7-h3-targeted-car-t-cells-for-treatment-of-atypical-teratoid-rhabdoid-tumors 2026-09-07T15:32:24.787Z https://www.parkerici.org/our-model/published-research/systemic-dysfunction-and-plasticity-of-the-immune-macroenvironment-in-cancer-models 2026-09-07T15:32:25.215Z https://www.parkerici.org/our-model/published-research/intratumoral-cd4-t-cells-mediate-anti-tumor-cytotoxicity-in-human-bladder-cancer-2 2026-09-07T15:32:25.687Z https://www.parkerici.org/our-model/published-research/sotigalimab-and-or-nivolumab-with-chemotherapy-in-first-line-metastatic-pancreatic-cancer-clinical-and-immunologic-analyses-from-the-randomized-phase-2-prince-trial 2026-09-28T20:47:45.577Z https://www.parkerici.org/our-model/published-research/overcoming-t-cell-tolerance-to-tumor-self-antigens-through-catch-bond-engineering 2026-09-29T16:42:55.265Z https://www.parkerici.org/our-model/published-research/in-vivo-site-specific-engineering-to-reprogram-t-cells 2026-09-28T21:20:25.701Z https://www.parkerici.org/our-model/published-research/neoadjuvant-pd-1-blockade-in-surgically-resectable-desmoplastic-melanoma-cohort-a-of-the-phase-2-swog-s1512-trial 2026-09-29T16:44:20.861Z https://www.parkerici.org/our-model/research-focuses/next-gen-cell-therapies-solid-tumors 2026-09-23T16:06:56.736Z https://www.parkerici.org/our-model/research-focuses/neoantigen-driven-targeting 2026-09-23T16:05:48.238Z https://www.parkerici.org/our-model/research-focuses/cancer-vaccines 2026-09-25T16:46:06.964Z https://www.parkerici.org/our-model/research-focuses/in-vivo-engineering 2026-09-25T16:47:03.541Z https://www.parkerici.org/our-model/research-focuses/systems-immunology 2026-09-23T16:02:20.517Z